Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2010, Vol. 15 ›› Issue (9): 1035-1039.

Previous Articles     Next Articles

Pharmacokinetic reseach of anti-cancer drug-Gemcitabine in vivo model by microdialysis technique

XIE Bo1, LING Jia-jun2, WU Xiu-jun2, FU Xiang2, HUANG Xue-qin1   

  1. 1Department of Oncology, General Military Hospital of Guangzhou, Guangzhou 510010, Guangdong,China;
    2College of Pharmacy, Guangzhou University of Chinese Medicine, Guangzhou 510006,Guangdong, China
  • Received:2010-08-08 Revised:2010-09-15 Online:2010-09-26 Published:2020-09-17

Abstract: AIM: To estabalish the methodology of microdialysis technique in pharmacokinetic(PK) reseach of anticancer drugs in vivo.METHODS: Gemcitabine (GEM) was injected into mice's tail vein. The microdialysate samples from blood were collected after dosing in gemcitabine-treated mices. The concentration of GEM was detected real-time continuously and pharmacokinetic parameters were evaluated.RESULTS: The recovery rate of GEM in vivo was (11.9±2.0)%. It showed that the pharmacokinetics of gemcitabine was two-compartment model in vivo and the elimination and distribution of GEM meets the first kinetics. There were no serious side effects in model mice.CONCLUSION: Microdialysis can be successfully employed in living body to detect the concentration of GEM continuously, which prompts it is possible to study the PK of anticancer drugs in malignant tissues in vivo.

Key words: Microdialysis, Gemcitabine, Anticancer drugs, Pharmacokinetic

CLC Number: